BSE - Delayed Quote INR

Concord Drugs Limited (CONCORD.BO)

30.37
-0.04
(-0.13%)
At close: June 13 at 3:27:14 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
452,446
452,446
449,245
520,806
589,565
Cost of Revenue
352,304
352,304
332,540
410,049
421,365
Gross Profit
100,142
100,142
116,705
110,757
168,200
Operating Expense
73,107
73,107
91,832
80,351
76,600
Operating Income
27,035
27,035
24,873
30,406
91,600
Net Non Operating Interest Income Expense
-20,267
-20,267
-18,676
-17,947
-17,657
Pretax Income
6,914
6,914
6,290
12,489
22,481
Tax Provision
3,552
3,552
1,566
2,634
6,537
Net Income Common Stockholders
3,362
3,362
4,724
9,855
15,943
Diluted NI Available to Com Stockholders
3,362
3,362
4,724
9,855
15,943
Basic EPS
0.34
--
0.47
1.06
1.82
Diluted EPS
0.34
--
0.47
1.06
1.82
Basic Average Shares
9,888.24
--
10,051.06
9,315
8,744
Diluted Average Shares
9,888.24
--
10,051.06
9,315
8,744
Total Expenses
425,411
425,411
424,372
490,400
497,965
Net Income from Continuing & Discontinued Operation
3,362
3,362
4,724
9,855
15,943
Normalized Income
3,362
3,362
4,724
9,855
52,457.96
Interest Income
--
--
92
60
123
Interest Expense
20,267
20,267
18,676
17,283
16,767
Net Interest Income
-20,267
-20,267
-18,676
-17,947
-17,657
EBIT
27,181
27,181
24,966
29,772
39,248
EBITDA
41,489
41,489
40,520
46,028
56,893
Reconciled Cost of Revenue
352,304
352,304
332,540
410,049
421,365
Reconciled Depreciation
14,308
14,308
15,554
16,255.80
17,645
Net Income from Continuing Operation Net Minority Interest
3,362
3,362
4,724
9,855
15,943
Total Unusual Items Excluding Goodwill
0
0
0
-148
-51,486
Total Unusual Items
0
0
0
-148
-51,486
Normalized EBITDA
41,489
41,489
40,520
46,028
108,379
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-14,971.04
3/31/2022 - 12/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CHCL.BO Cian Healthcare Ltd
4.1200
+1.73%
 
VIKRAMTH.BO Vikram Thermo (India) Limited
167.35
-0.12%
 
SIGACHI.NS Sigachi Industries Limited
58.43
+1.71%
 
SYNCOMF.NS Syncom Formulations (India) Limited
21.50
-1.60%
 
SEQUENT.NS Sequent Scientific Limited
197.26
+1.37%
 
PPLPHARMA.NS Piramal Pharma Limited
200.22
+0.15%